EP1176979A4 - Preparation a forte teneur en immunoglobuline et ses procedes de production - Google Patents

Preparation a forte teneur en immunoglobuline et ses procedes de production

Info

Publication number
EP1176979A4
EP1176979A4 EP00924972A EP00924972A EP1176979A4 EP 1176979 A4 EP1176979 A4 EP 1176979A4 EP 00924972 A EP00924972 A EP 00924972A EP 00924972 A EP00924972 A EP 00924972A EP 1176979 A4 EP1176979 A4 EP 1176979A4
Authority
EP
European Patent Office
Prior art keywords
production
high concentration
immunoglobulin preparation
concentration immunoglobulin
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00924972A
Other languages
German (de)
English (en)
Other versions
EP1176979A1 (fr
Inventor
Germano Coppola
Joseph Bertolini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Ltd
Original Assignee
CSL Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CSL Ltd filed Critical CSL Ltd
Publication of EP1176979A1 publication Critical patent/EP1176979A1/fr
Publication of EP1176979A4 publication Critical patent/EP1176979A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP00924972A 1999-05-10 2000-05-10 Preparation a forte teneur en immunoglobuline et ses procedes de production Withdrawn EP1176979A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPQ026799 1999-05-10
AUPQ0267A AUPQ026799A0 (en) 1999-05-10 1999-05-10 Method of increasing protein stability by removing immunoglobulin aggregates
PCT/AU2000/000433 WO2000067789A1 (fr) 1999-05-10 2000-05-10 Preparation a forte teneur en immunoglobuline et ses procedes de production

Publications (2)

Publication Number Publication Date
EP1176979A1 EP1176979A1 (fr) 2002-02-06
EP1176979A4 true EP1176979A4 (fr) 2005-05-04

Family

ID=3814474

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00924972A Withdrawn EP1176979A4 (fr) 1999-05-10 2000-05-10 Preparation a forte teneur en immunoglobuline et ses procedes de production

Country Status (3)

Country Link
EP (1) EP1176979A4 (fr)
AU (1) AUPQ026799A0 (fr)
WO (1) WO2000067789A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040033228A1 (en) 2002-08-16 2004-02-19 Hans-Juergen Krause Formulation of human antibodies for treating TNF-alpha associated disorders
US8536315B2 (en) 2004-01-30 2013-09-17 Shire Pharmaceuticals Ireland Limited Production and purification of recombinant arylsulftase
ES2928096T3 (es) * 2006-04-04 2022-11-15 Takeda Pharmaceuticals Co Un proceso para la concentración de un polipéptido
CA2681752A1 (fr) 2007-03-29 2008-10-09 Abbott Laboratories Anticorps anti-1l-12 humains cristallins
US8883146B2 (en) 2007-11-30 2014-11-11 Abbvie Inc. Protein formulations and methods of making same
US20110166332A1 (en) * 2008-09-12 2011-07-07 Ge Healthcare Bio-Sciences Ab Enhanced antibody aggregate removal with capto adhere in the presence of protein-excluded zwitterions
MX2011012576A (es) 2009-05-27 2012-05-08 Baxter Int Metodo para producir una preparacion altamente concentrada de inmunoglobulina de uso subcutaneo.
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
ES2625511T3 (es) 2011-07-08 2017-07-19 Shire Human Genetic Therapies, Inc. Métodos para la purificación de arylsulfatasa A
WO2014039903A2 (fr) 2012-09-07 2014-03-13 Coherus Biosciences, Inc. Formulations aqueuses stables d'adalimumab
AU2014205441B2 (en) 2013-01-09 2019-12-12 Takeda Pharmaceutical Company Limited Methods for purification of arylsulfatase A
US11229702B1 (en) 2015-10-28 2022-01-25 Coherus Biosciences, Inc. High concentration formulations of adalimumab
WO2017184880A1 (fr) 2016-04-20 2017-10-26 Coherus Biosciences, Inc. Procédé de remplissage d'un récipient sans espace libre
FI3684407T3 (fi) 2017-09-20 2026-03-13 Alvotech Hf Adalimumabin farmaseuttisia formulaatioita

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656730A (en) * 1995-04-07 1997-08-12 Enzon, Inc. Stabilized monomeric protein compositions
WO1998042376A1 (fr) * 1997-03-20 1998-10-01 Common Services Agency Composition contenant de l'immunoglobuline

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3310150A1 (de) * 1983-03-21 1984-09-27 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung einer nebenwirkungsfreien igg-immunglobulinloesung fuer die intravenoese applikation
US4597966A (en) * 1985-01-09 1986-07-01 Ortho Diagnostic Systems, Inc. Histidine stabilized immunoglobulin and method of preparation
CA1310267C (fr) * 1986-07-09 1992-11-17 Yutaka Hirao Procede pour le thermotraitement de _-globuline non modifiee
DE3641115A1 (de) * 1986-12-02 1988-06-16 Lentia Gmbh Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins
AU3429797A (en) * 1996-07-18 1998-02-10 Csl Limited Pasteurization of immunoglobulin solutions
NZ509135A (en) * 1998-06-09 2002-10-25 Statens Seruminstitut A third generation intravenous immunoglobulin G (IVIG) purified using column chromatographic ion exchange methods

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656730A (en) * 1995-04-07 1997-08-12 Enzon, Inc. Stabilized monomeric protein compositions
WO1998042376A1 (fr) * 1997-03-20 1998-10-01 Common Services Agency Composition contenant de l'immunoglobuline

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0067789A1 *

Also Published As

Publication number Publication date
WO2000067789A1 (fr) 2000-11-16
AUPQ026799A0 (en) 1999-06-03
EP1176979A1 (fr) 2002-02-06

Similar Documents

Publication Publication Date Title
GB2363756B (en) Absorbent structure and method for production
HUP0203386A3 (en) Magnetic glass particles, method for their preparation and uses thereof
EP1243335A4 (fr) Catalyseur et procede de preparation correspondant
GB9828640D0 (en) Novel method and compounds
HUP0003120A3 (en) Method and apparatus for production oxide nano-crystales
HUP0104957A3 (en) Method for producing 3-alkanoylindoles and 3-alkylindoles
EP1176979A4 (fr) Preparation a forte teneur en immunoglobuline et ses procedes de production
GB9918901D0 (en) Ion-exchange filter,method of manufacturing the filter and the filter apparatus using the filter
HUP0101779A3 (en) Process for de-chlorinating and de-fouling waste-oil
EP1146136A4 (fr) Ornement et son procede de preparation
GB2334231B (en) Apparatus and method for manufacturing furniture
GB9819651D0 (en) Matrerial and process for its production
HUP0103749A3 (en) Tricyclic delta3-piperidines as pharmaceuticals and process for their preparation
GB2389182B (en) Method of purifying b-secretase
HUP0002751A3 (en) Novel grignard-reagents and process for producing thereof
HUP0105166A3 (en) Substances wk-5344a and wk-5344b and process for producing the same
GB9822837D0 (en) Improved carton and method for manufacture thereof
GB9922456D0 (en) Method and apparatus for crop production
IL129330A (en) Phenoxy-phenylsulfonic acid derivatives and process for their preparation
EP1111046A4 (fr) Nouvelle proteine et son procede de production
HU0303170D0 (en) Method for the production of 2-coumarone and substituted 2-coumarones
IL140739A0 (en) Glyceryl trinitrate-containing preparation, method for its production, and its use
HUP0101730A3 (en) Method for preparing and using b-starch
HUP0104386A3 (en) Method for producing l-prolyl-l-m-sarcolysyl-l-p-fluorophenylalanine and derivatives thereof
GB9929632D0 (en) Insulation component and process for its production

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011029

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20050323

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050609